Commit To Buy Clovis Oncology At $65, Earn 16.4% Annualized Using Options
March 06, 2015 at 11:32 AM EST
Investors eyeing a purchase of Clovis Oncology Inc (CLVS) stock, but cautious about paying the going market price of $78.23/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2016 put at the $65 strike, which has a bid at the time of this writing of $9.20..